Authors:
Taylor, DD
Bender, DP
Gercel-Taylor, C
Stanson, J
Whiteside, T
Citation: Dd. Taylor et al., Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients, BR J CANC, 84(12), 2001, pp. 1624-1629
Authors:
deMagalhaes-Silverman, M
Donnenberg, A
Lembersky, B
Elder, E
Lister, J
Rybka, W
Whiteside, T
Ball, E
Citation: M. Demagalhaes-silverman et al., Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer, J IMMUNOTH, 23(1), 2000, pp. 154-160
Authors:
Okada, H
Pollack, IF
Lotze, MT
Lunsford, LD
Kondziolka, D
Lieberman, F
Schiff, D
Attanucci, J
Edington, H
Chambers, W
Robbins, P
Baar, J
Kinzler, D
Whiteside, T
Elder, E
Citation: H. Okada et al., Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response, HUM GENE TH, 11(4), 2000, pp. 637-653
Citation: Yp. Sun et al., Preparation of nanoscale semiconductors through the rapid expansion of supercritical solution (RESS) into liquid solution, IND ENG RES, 39(12), 2000, pp. 4663-4669
Authors:
Rosenbloom, AJ
Pinsky, MR
Napolitano, C
Nguyen, TS
Levann, D
Pencosky, N
Dorrance, A
Ray, BK
Whiteside, T
Citation: Aj. Rosenbloom et al., Suppression of cytokine-mediated beta(2)-integrin activation on circulating neutrophils in critically ill patients, J LEUK BIOL, 66(1), 1999, pp. 83-89